Area: Oncology , Respiratory
Location: Geneva, Switzerland
Date: April 13 to April 16
Description:
European Lung Cancer Conference.
SCLC genomic alterations, HER2 mutations, predictions for immunotherapy
Finding predictors of immunotherapy, advancements in targeted therapy - the IASLC perspective
Novelties in radiotherapy of lung cancer
State of art - immunotherapy in lung cancer
Securing precise diagnosis in lung cancer - the pathologist's view
EPIDAURE study: Real-life practice of gefitinib in NSCLC
The future of LC therapy is combination
The real price of smoking and how to quit
Lung cancer prevention and the feasibility of screening programs